Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate.
1986; Lippincott Williams & Wilkins; Volume: 8; Issue: 2 Linguagem: Inglês
10.1161/01.hyp.8.2.93
ISSN1524-4563
Autores Tópico(s)Coagulation, Bradykinin, Polyphosphates, and Angioedema
ResumoHomeHypertensionVol. 8, No. 2Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBSyndrome of hypertension and hyperkalemia with normal glomerular filtration rate. R D Gordon R D GordonR D Gordon Originally published1 Feb 1986https://doi.org/10.1161/01.HYP.8.2.93Hypertension. 1986;8:93–102 Previous Back to top Next FiguresReferencesRelatedDetailsCited ByChatrathi H, Collins J, Wolfe L, Markello T, Adams D, Gahl W, Werner A and Sharma P (2021) Novel CUL3 Variant Causing Familial Hyperkalemic Hypertension Impairs Regulation and Function of Ubiquitin Ligase Activity, Hypertension, 79:1, (60-75), Online publication date: 1-Jan-2022. Larkins N and Roebuck D (2022) Diagnostic Evaluation of Pediatric Hypertension Pediatric Hypertension, 10.1007/978-3-319-31420-4_32-2, (1-17), . Marcoux A, Tremblay L, Slimani S, Fiola M, Mac‐Way F, Haydock L, Garneau A and Isenring P (2021) Anatomophysiology of the Henle's Loop: Emphasis on the Thick Ascending Limb Comprehensive Physiology, 10.1002/cphy.c210021, (3119-3139) Zhang R, Zhang S, Luo Y, Li M, Wen X, Cai X, Han X and Ji L (2021) A case report of pseudohypoaldosteronism type II with a homozygous KLHL3 variant accompanied by hyperthyroidism, BMC Endocrine Disorders, 10.1186/s12902-021-00767-w, 21:1, Online publication date: 1-Dec-2021. Hureaux M, Mazurkiewicz S, Boccio V, Vargas-Poussou R and Jeunemaitre X (2021) The variety of genetic defects explains the phenotypic heterogeneity of Familial Hyperkalemic Hypertension, Kidney International Reports, 10.1016/j.ekir.2021.07.025, 6:10, (2639-2652), Online publication date: 1-Oct-2021. Fujii S, Kikuchi E, Suzuyama H, Watanabe Y, Ishigami‐Yuasa M, Masuno H, Mori T, Isobe K, Uchida S and Kagechika H (2021) Structural Development of Salicylanilide‐Based SPAK Inhibitors as Candidate Antihypertensive Agents, ChemMedChem, 10.1002/cmdc.202100273, 16:18, (2817-2822), Online publication date: 16-Sep-2021. Adney J, Koehler S, Tian L and Maliakkal J (2021) Headache and Hypertension in a 9-year-old Girl, Pediatrics In Review, 10.1542/pir.2019-0119, 42:7, (383-386), Online publication date: 1-Jul-2021. Guo Q, Zhang Y, Jiang G and Zhang C (2021) Decreased KLHL3 expression is involved in the activation of WNK-OSR1/SPAK-NCC cascade in type 1 diabetic mice, Pflügers Archiv - European Journal of Physiology, 10.1007/s00424-020-02509-8, 473:2, (185-196), Online publication date: 1-Feb-2021. Larkins N, Lurbe E and Flynn J (2021) Evaluation and Management of Hypertension in Children Pediatric Nephrology, 10.1007/978-3-642-27843-3_123-1, (1-26), . Yu G, Hashim F, Macmurdo C and Hanna C (2020) Persistent hyperkalemia in an otherwise healthy 4-month-old female: Answers, Pediatric Nephrology, 10.1007/s00467-020-04575-7, 35:11, (2099-2100), Online publication date: 1-Nov-2020. Nakashima M, Kato M, Matsukura M, Kira R, Ngu L, Lichtenbelt K, van Gassen K, Mitsuhashi S, Saitsu H and Matsumoto N (2020) De novo variants in CUL3 are associated with global developmental delays with or without infantile spasms, Journal of Human Genetics, 10.1038/s10038-020-0758-2, 65:9, (727-734), Online publication date: 1-Sep-2020. Fujii S, Kikuchi E, Watanabe Y, Suzuyama H, Ishigami-Yuasa M, Mori T, Isobe K, Uchida S and Kagechika H (2020) Structural development of N-(4-phenoxyphenyl)benzamide derivatives as novel SPAK inhibitors blocking WNK kinase signaling, Bioorganic & Medicinal Chemistry Letters, 10.1016/j.bmcl.2020.127408, 30:17, (127408), Online publication date: 1-Sep-2020. Furusho T, Uchida S and Sohara E (2020) The WNK signaling pathway and salt-sensitive hypertension, Hypertension Research, 10.1038/s41440-020-0437-x, 43:8, (733-743), Online publication date: 1-Aug-2020. Rossi G, Regolisti G, Peyronel F and Fiaccadori E (2020) Recent insights into sodium and potassium handling by the aldosterone-sensitive distal nephron: implications on pathophysiology and drug discovery, Journal of Nephrology, 10.1007/s40620-020-00700-9, 33:3, (447-466), Online publication date: 1-Jun-2020. Yavas Abali Z, Yesil G, Kirkgoz T, Cicek N, Alpay H, Turan S, Bereket A and Guran T (2019) Rare cause of severe hypertension in an adolescent boy presenting with short stature: Answers, Pediatric Nephrology, 10.1007/s00467-019-04352-1, 35:3, (405-407), Online publication date: 1-Mar-2020. Subramanya A (2020) Thiazide-Sensitive NaCl Cotransporter Studies of Epithelial Transporters and Ion Channels, 10.1007/978-3-030-55454-5_3, (57-92), . Leiz J and Schmidt-Ott K (2019) Claudins in the Renal Collecting Duct, International Journal of Molecular Sciences, 10.3390/ijms21010221, 21:1, (221) Mutig K and Bachmann S (2019) Hyperkalemia and blood pressure regulation, Nephrology Dialysis Transplantation, 10.1093/ndt/gfz218, 34:Supplement_3, (iii26-iii35), Online publication date: 1-Dec-2019. Wu A, Wolley M and Stowasser M (2019) The interplay of renal potassium and sodium handling in blood pressure regulation: critical role of the WNK-SPAK-NCC pathway, Journal of Human Hypertension, 10.1038/s41371-019-0170-6, 33:7, (508-523), Online publication date: 1-Jul-2019. Weiner I and Verlander J (2019) Emerging Features of Ammonia Metabolism and Transport in Acid-Base Balance, Seminars in Nephrology, 10.1016/j.semnephrol.2019.04.008, 39:4, (394-405), Online publication date: 1-Jul-2019. Wang L, Jiang C, Cai R, Chen X and Peng J (2019) Unveiling the Distinct Mechanisms by which Disease-Causing Mutations in the Kelch Domain of KLHL3 Disrupt the Interaction with the Acidic Motif of WNK4 through Molecular Dynamics Simulation, Biochemistry, 10.1021/acs.biochem.9b00066, 58:16, (2105-2115), Online publication date: 23-Apr-2019. Markel A (2019) Genetics and pathophysiology of low-renin arterial hypertension, Vavilov Journal of Genetics and Breeding, 10.18699/VJ18.443, 22:8, (1000-1008) Rafael C, Soukaseum C, Baudrie V, Frère P and Hadchouel J (2018) Consequences of SPAK inactivation on Hyperkalemic Hypertension caused by WNK1 mutations: evidence for differential roles of WNK1 and WNK4, Scientific Reports, 10.1038/s41598-018-21405-x, 8:1, Online publication date: 1-Dec-2018. Yoshida S, Araki Y, Mori T, Sasaki E, Kasagi Y, Isobe K, Susa K, Inoue Y, Bomont P, Okado T, Rai T, Uchida S and Sohara E (2018) Decreased KLHL3 expression is involved in the pathogenesis of pseudohypoaldosteronism type II caused by cullin 3 mutation in vivo, Clinical and Experimental Nephrology, 10.1007/s10157-018-1593-z, 22:6, (1251-1257), Online publication date: 1-Dec-2018. Terker A, Castañeda-Bueno M, Ferdaus M, Cornelius R, Erspamer K, Su X, Miller L, McCormick J, Wang W, Gamba G, Yang C and Ellison D (2018) With no lysine kinase 4 modulates sodium potassium 2 chloride cotransporter activity in vivo, American Journal of Physiology-Renal Physiology, 10.1152/ajprenal.00485.2017, 315:4, (F781-F790), Online publication date: 1-Oct-2018. López-Cayuqueo K, Chavez-Canales M, Pillot A, Houillier P, Jayat M, Baraka-Vidot J, Trepiccione F, Baudrie V, Büsst C, Soukaseum C, Kumai Y, Jeunemaître X, Hadchouel J, Eladari D and Chambrey R (2018) A mouse model of pseudohypoaldosteronism type II reveals a novel mechanism of renal tubular acidosis, Kidney International, 10.1016/j.kint.2018.05.001, 94:3, (514-523), Online publication date: 1-Sep-2018. Batlle D and Arruda J (2018) Hyperkalemic Forms of Renal Tubular Acidosis: Clinical and Pathophysiological Aspects, Advances in Chronic Kidney Disease, 10.1053/j.ackd.2018.05.004, 25:4, (321-333), Online publication date: 1-Jul-2018. Awad S, Keely E and Abujrad H (2018) Resolution of Metabolic Abnormalities During Pregnancy in a Patient with Gordon Syndrome and KLHL3 Mutation, AACE Clinical Case Reports, 10.4158/AACR-2017-0006, 4:3, (235-239), Online publication date: 1-May-2018. Harris A, Grimm P, Lee H, Delpire E, Fang L, Verlander J, Welling P and Weiner I (2018) Mechanism of Hyperkalemia-Induced Metabolic Acidosis, Journal of the American Society of Nephrology, 10.1681/ASN.2017111163, 29:5, (1411-1425), Online publication date: 1-May-2018. Nadal J, Channavajjhala S, Jia W, Clayton J, Hall I and Glover M (2018) Clinical and Molecular Features of Thiazide-Induced Hyponatremia, Current Hypertension Reports, 10.1007/s11906-018-0826-6, 20:4, Online publication date: 1-Apr-2018. Shao L, Cui L, Lu J, Lang Y, Bottillo I and Zhao X (2018) A novel mutation in exon 9 of Cullin 3 gene contributes to aberrant splicing in pseudohypoaldosteronism type II, FEBS Open Bio, 10.1002/2211-5463.12389, 8:3, (461-469), Online publication date: 1-Mar-2018. Ahn S and Gupta C (2018) Genetic Programming of Hypertension, Frontiers in Pediatrics, 10.3389/fped.2017.00285, 5 Ehret G (2018) Genetics of Hypertension Hypertension: A Companion to Braunwald's Heart Disease, 10.1016/B978-0-323-42973-3.00006-8, (52-59), . Stojanović V, Spasojević S, Radovanović T and Doronjski A (2017) Pseudohypoaldosteronism: report of three cases, Journal of Endocrinology, Metabolism and Diabetes of South Africa, 10.1080/16089677.2017.1335532, 22:2, (17-20), Online publication date: 4-May-2017. Kasagi Y, Takahashi D, Aida T, Nishida H, Nomura N, Zeniya M, Mori T, Sasaki E, Ando F, Rai T, Uchida S and Sohara E (2017) Impaired degradation of medullary WNK4 in the kidneys of KLHL2 knockout mice, Biochemical and Biophysical Research Communications, 10.1016/j.bbrc.2017.04.068, 487:2, (368-374), Online publication date: 1-May-2017. Sasaki E, Susa K, Mori T, Isobe K, Araki Y, Inoue Y, Yoshizaki Y, Ando F, Mori Y, Mandai S, Zeniya M, Takahashi D, Nomura N, Rai T, Uchida S and Sohara E (2017) KLHL3 Knockout Mice Reveal the Physiological Role of KLHL3 and the Pathophysiology of Pseudohypoaldosteronism Type II Caused by Mutant KLHL3 , Molecular and Cellular Biology, 10.1128/MCB.00508-16, 37:7, Online publication date: 1-Apr-2017. Wang L and Peng J (2016) Phosphorylation of KLHL3 at serine 433 impairs its interaction with the acidic motif of WNK4: a molecular dynamics study, Protein Science, 10.1002/pro.3063, 26:2, (163-173), Online publication date: 1-Feb-2017. Hollander R, Mortier G and van Hoeck K (2016) Hyperkalemia in young children: blood pressure checked?, European Journal of Pediatrics, 10.1007/s00431-016-2782-y, 175:12, (2011-2013), Online publication date: 1-Dec-2016. Hou J (2016) Paracellular transport in the collecting duct, Current Opinion in Nephrology and Hypertension, 10.1097/MNH.0000000000000253, 25:5, (424-428), Online publication date: 1-Sep-2016. Sohara E and Uchida S (2015) Kelch-like 3/Cullin 3 ubiquitin ligase complex and WNK signaling in salt-sensitive hypertension and electrolyte disorder, Nephrology Dialysis Transplantation, 10.1093/ndt/gfv259, 31:9, (1417-1424), Online publication date: 1-Sep-2016. Dbouk H, Huang C and Cobb M (2016) Hypertension: the missing WNKs, American Journal of Physiology-Renal Physiology, 10.1152/ajprenal.00358.2015, 311:1, (F16-F27), Online publication date: 1-Jul-2016. Mitani M, Furuichi M, Narumi S, Hasegawa T, Chiga M, Uchida S and Sato S (2016) A patient with pseudohypoaldosteronism type II complicated by congenital hypopituitarism carrying a KLHL3 mutation, Clinical Pediatric Endocrinology, 10.1297/cpe.25.127, 25:4, (127-134), . Lurbe E and Simonetti G (2016) Childhood Hypertension: Epidemiology, Etiology, Target Organ Damage, and Consequences Pediatric Kidney Disease, 10.1007/978-3-662-52972-0_49, (1313-1338), . Quigley R and Wolf M (2016) Renal Tubular Acidosis in Children Pediatric Nephrology, 10.1007/978-3-662-43596-0_35, (1273-1306), . Subramanya A (2016) Thiazide-Sensitive NaCl Cotransporter Ion Channels and Transporters of Epithelia in Health and Disease, 10.1007/978-1-4939-3366-2_12, (401-435), . Yoshizaki Y, Mori Y, Tsuzaki Y, Mori T, Nomura N, Wakabayashi M, Takahashi D, Zeniya M, Kikuchi E, Araki Y, Ando F, Isobe K, Nishida H, Ohta A, Susa K, Inoue Y, Chiga M, Rai T, Sasaki S, Uchida S and Sohara E (2015) Impaired degradation of WNK by Akt and PKA phosphorylation of KLHL3, Biochemical and Biophysical Research Communications, 10.1016/j.bbrc.2015.09.184, 467:2, (229-234), Online publication date: 1-Nov-2015. Schumacher F, Siew K, Zhang J, Johnson C, Wood N, Cleary S, Al Maskari R, Ferryman J, Hardege I, Yasmin , Figg N, Enchev R, Knebel A, O'Shaughnessy K and Kurz T (2015) Characterisation of the Cullin‐3 mutation that causes a severe form of familial hypertension and hyperkalaemia, EMBO Molecular Medicine, 10.15252/emmm.201505444, 7:10, (1285-1306), Online publication date: 1-Oct-2015. King M, Garçon L, Hoyer J, Iolascon A, Picard V, Stewart G, Bianchi P, Lee S and Zanella A (2015) ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders, International Journal of Laboratory Hematology, 10.1111/ijlh.12335, 37:3, (304-325), Online publication date: 1-Jun-2015. Gong Y, Wang J, Yang J, Gonzales E, Perez R and Hou J (2015) KLHL3 regulates paracellular chloride transport in the kidney by ubiquitination of claudin-8, Proceedings of the National Academy of Sciences, 10.1073/pnas.1421441112, 112:14, (4340-4345), Online publication date: 7-Apr-2015. Liu Y, Song X, Shi Y, Shi Z, Niu W, Feng X, Gu D, Bao H, Ma H, Eaton D, Zhuang J and Cai H (2014) WNK1 Activates Large-Conductance Ca 2+ -Activated K + Channels through Modulation of ERK1/2 Signaling , Journal of the American Society of Nephrology, 10.1681/ASN.2014020186, 26:4, (844-854), Online publication date: 1-Apr-2015. Nishimoto M and Fujita T (2015) Renal mechanisms of salt-sensitive hypertension: contribution of two steroid receptor-associated pathways, American Journal of Physiology-Renal Physiology, 10.1152/ajprenal.00477.2013, 308:5, (F377-F387), Online publication date: 1-Mar-2015. Mayan H, Carmon V, Oleinikov K, London S, Halevy R, Holtzman E, Tenenbaum-Rakover Y, Farfel Z and Hanukoglu A (2015) Hypercalciuria in Familial Hyperkalemia and Hypertension with KLHL3 Mutations, Nephron, 10.1159/000381563, 130:1, (59-65), . Susa K, Sohara E, Rai T, Zeniya M, Mori Y, Mori T, Chiga M, Nomura N, Nishida H, Takahashi D, Isobe K, Inoue Y, Takeishi K, Takeda N, Sasaki S and Uchida S (2014) Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice, Human Molecular Genetics, 10.1093/hmg/ddu217, 23:19, (5052-5060), Online publication date: 1-Oct-2014. (2014) Index of Suspicion in the Nursery, NeoReviews, 10.1542/neo.15-9-e403, 15:9, (e403-e407), Online publication date: 1-Sep-2014. Uchida S (2014) Regulation of blood pressure and renal electrolyte balance by Cullin-RING ligases, Current Opinion in Nephrology and Hypertension, 10.1097/MNH.0000000000000049, 23:5, (487-493), Online publication date: 1-Sep-2014. Magill S (2014) Pathophysiology, Diagnosis, and Treatment of Mineralocorticoid Disorders Comprehensive Physiology, 10.1002/cphy.c130042, (1083-1119) Lagnaz D, Arroyo J, Chávez-Canales M, Vázquez N, Rizzo F, Spirlí A, Debonneville A, Staub O and Gamba G (2014) WNK3 abrogates the NEDD4-2-mediated inhibition of the renal Na + -Cl − cotransporter , American Journal of Physiology-Renal Physiology, 10.1152/ajprenal.00574.2013, 307:3, (F275-F286), Online publication date: 1-Aug-2014. Glover M, Ware J, Henry A, Wolley M, Walsh R, Wain L, Xu S, Van't Hoff W, Tobin M, Hall I, Cook S, Gordon R, Stowasser M and O'Shaughnessy K (2014) Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon's syndrome) , Clinical Science, 10.1042/CS20130326, 126:10, (721-726), Online publication date: 1-May-2014. Uchida S, Sohara E, Rai T and Sasaki S (2014) Regulation of with‐no‐lysine kinase signaling by Kelch‐like proteins, Biology of the Cell, 10.1111/boc.201300069, 106:2, (45-56), Online publication date: 1-Feb-2014. Nagahara K, Abe Y, Hojo A, Dobashi K, Chiga M, Isobe K, Uchida S and Itabashi K (2014) Evaluation of Phosphorylated Urinary Na-Cl Cotransporter Is Potentially Useful in a Patient With Pseudohypoaldosteronism Type II due to Mutation in CUL3 , Global Pediatric Health, 10.1177/2333794X14552899, 1, (2333794X1455289), Online publication date: 1-Jan-2014. Salpietro V, Polizzi A, Di Rosa G, Romeo A, Dipasquale V, Morabito P, Chirico V, Arrigo T and Ruggieri M (2014) Adrenal Disorders and the Paediatric Brain: Pathophysiological Considerations and Clinical Implications, International Journal of Endocrinology, 10.1155/2014/282489, 2014, (1-15), . Quigley R and Wolf M (2014) Renal Tubular Acidosis in Children Pediatric Nephrology, 10.1007/978-3-642-27843-3_35-1, (1-40), . Stowasser M and Gordon R (2014) The Aldosterone–Renin Ratio: Role and Problems Primary Aldosteronism, 10.1007/978-1-4939-0509-6_9, (109-126), . Pathare G, Hoenderop J, Bindels R and San-Cristobal P (2013) A molecular update on pseudohypoaldosteronism type II, American Journal of Physiology-Renal Physiology, 10.1152/ajprenal.00440.2013, 305:11, (F1513-F1520), Online publication date: 1-Dec-2013. Siew K and O'Shaughnessy K (2013) Extrarenal roles of the with-no-lysine[K] kinases (WNKs), Clinical and Experimental Pharmacology and Physiology, 10.1111/1440-1681.12108, 40:12, (885-894), Online publication date: 1-Dec-2013. Zeniya M, Sohara E, Kita S, Iwamoto T, Susa K, Mori T, Oi K, Chiga M, Takahashi D, Yang S, Lin S, Rai T, Sasaki S and Uchida S (2013) Dietary Salt Intake Regulates WNK3–SPAK–NKCC1 Phosphorylation Cascade in Mouse Aorta Through Angiotensin II, Hypertension, 62:5, (872-878), Online publication date: 1-Nov-2013. Isobe K, Mori T, Asano T, Kawaguchi H, Nonoyama S, Kumagai N, Kamada F, Morimoto T, Hayashi M, Sohara E, Rai T, Sasaki S and Uchida S (2013) Development of enzyme-linked immunosorbent assays for urinary thiazide-sensitive Na-Cl cotransporter measurement, American Journal of Physiology-Renal Physiology, 10.1152/ajprenal.00208.2013, 305:9, (F1374-F1381), Online publication date: 1-Nov-2013. Mori T, Kikuchi E, Watanabe Y, Fujii S, Ishigami-Yuasa M, Kagechika H, Sohara E, Rai T, Sasaki S and Uchida S (2013) Chemical library screening for WNK signalling inhibitors using fluorescence correlation spectroscopy, Biochemical Journal, 10.1042/BJ20130597, 455:3, (339-345), Online publication date: 1-Nov-2013. Chu P, Cheng C, Wu Y, Fang Y, Chau T, Uchida S, Sasaki S, Yang S, Lin S and Dussaule J (2013) SPAK Deficiency Corrects Pseudohypoaldosteronism II Caused by WNK4 Mutation, PLoS ONE, 10.1371/journal.pone.0072969, 8:9, (e72969) Shimizu M, Goto T, Sato A and Shibuya H (2013) WNK 4 is an essential effector of anterior formation in FGF signaling , Genes to Cells, 10.1111/gtc.12048, 18:6, (442-449), Online publication date: 1-Jun-2013. Jain G, Ong S and Warnock D (2013) Genetic Disorders of Potassium Homeostasis, Seminars in Nephrology, 10.1016/j.semnephrol.2013.04.010, 33:3, (300-309), Online publication date: 1-May-2013. Wakabayashi M, Mori T, Isobe K, Sohara E, Susa K, Araki Y, Chiga M, Kikuchi E, Nomura N, Mori Y, Matsuo H, Murata T, Nomura S, Asano T, Kawaguchi H, Nonoyama S, Rai T, Sasaki S and Uchida S (2013) Impaired KLHL3-Mediated Ubiquitination of WNK4 Causes Human Hypertension, Cell Reports, 10.1016/j.celrep.2013.02.024, 3:3, (858-868), Online publication date: 1-Mar-2013. Sato A, Shibuya H and Verheyen E (2013) WNK Signaling Is Involved in Neural Development via Lhx8/Awh Expression, PLoS ONE, 10.1371/journal.pone.0055301, 8:1, (e55301) Krapf R, Seldin D and Alpern R (2013) Clinical Syndromes of Metabolic Acidosis Seldin and Giebisch's The Kidney, 10.1016/B978-0-12-381462-3.00059-8, (2049-2111), . Gamba G (2013) Physiology and Pathophysiology of the NaCl Co-Transporters in the Kidney Seldin and Giebisch's The Kidney, 10.1016/B978-0-12-381462-3.00032-X, (1047-1080), . Pereira-Mestre R, Giannini O, Manzocchi V and Bianchetti M (2012) Masked hypertension delaying diagnosis in Gordon's syndrome, Journal of Hypertension, 10.1097/HJH.0b013e3283580069, 30:11, (2240), Online publication date: 1-Nov-2012. Grimm P, Taneja T, Liu J, Coleman R, Chen Y, Delpire E, Wade J and Welling P (2012) SPAK Isoforms and OSR1 Regulate Sodium-Chloride Co-transporters in a Nephron-specific Manner, Journal of Biological Chemistry, 10.1074/jbc.M112.402800, 287:45, (37673-37690), Online publication date: 1-Nov-2012. Susa K, Sohara E, Isobe K, Chiga M, Rai T, Sasaki S and Uchida S (2012) WNK-OSR1/SPAK-NCC signal cascade has circadian rhythm dependent on aldosterone, Biochemical and Biophysical Research Communications, 10.1016/j.bbrc.2012.09.130, 427:4, (743-747), Online publication date: 1-Nov-2012. Nishida H, Sohara E, Nomura N, Chiga M, Alessi D, Rai T, Sasaki S and Uchida S (2012) Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Activates the WNK-OSR1/SPAK-NCC Phosphorylation Cascade in Hyperinsulinemic db/db Mice, Hypertension, 60:4, (981-990), Online publication date: 1-Oct-2012. Simonetti G, Mohaupt M and Bianchetti M (2011) Monogenic forms of hypertension, European Journal of Pediatrics, 10.1007/s00431-011-1440-7, 171:10, (1433-1439), Online publication date: 1-Oct-2012. Markadieu N, San-Cristobal P, Nair A, Verkaart S, Lenssen E, Tudpor K, van Zeeland F, Loffing J, Bindels R and Hoenderop J (2012) A primary culture of distal convoluted tubules expressing functional thiazide-sensitive NaCl transport, American Journal of Physiology-Renal Physiology, 10.1152/ajprenal.00114.2012, 303:6, (F886-F892), Online publication date: 15-Sep-2012. Pao A (2012) SGK regulation of renal sodium transport, Current Opinion in Nephrology & Hypertension, 10.1097/MNH.0b013e32835571be, 21:5, (534-540), Online publication date: 1-Sep-2012. Louis-Dit-Picard H, Hadchouel J and Jeunemaitre X (2012) KLHL3 et CULLIN-3 , médecine/sciences, 10.1051/medsci/2012288010, 28:8-9, (703-706), Online publication date: 1-Aug-2012. Susa K, Kita S, Iwamoto T, Yang S, Lin S, Ohta A, Sohara E, Rai T, Sasaki S, Alessi D and Uchida S (2012) Effect of heterozygous deletion of WNK1 on the WNK-OSR1/SPAK-NCC/NKCC1/NKCC2 signal cascade in the kidney and blood vessels, Clinical and Experimental Nephrology, 10.1007/s10157-012-0590-x, 16:4, (530-538), Online publication date: 1-Aug-2012. Edwards J (2012) Chloride Transport Comprehensive Physiology, 10.1002/cphy.c110027, (1061-1092) Oi K, Sohara E, Rai T, Misawa M, Chiga M, Alessi D, Sasaki S and Uchida S (2011) A minor role of WNK3 in regulating phosphorylation of renal NKCC2 and NCC co-transporters in vivo , Biology Open, 10.1242/bio.2011048, 1:2, (120-127), Online publication date: 15-Feb-2012. Pela I (2012) Familial Hyperkalemic Hypertension: A New Early-onset Pediatric Case, Clinical Pediatric Endocrinology, 10.1297/cpe.21.5, 21:1, (5-9), . Chan J, Santos F and Hand M (2012) Fluid, Electrolyte, and Acid-Base Disorders in Children Brenner and Rector's The Kidney, 10.1016/B978-1-4160-6193-9.10074-0, (2572-2621), . Kostakis I, Cholidou K and Perrea D (2012) Syndromes of impaired ion handling in the distal nephron: pseudohypoaldosteronism and familial hyperkalemic hypertension, Hormones, 10.1007/BF03401536, 11:1, (31-53), Online publication date: 1-Jan-2012. Sohara E, Rai T, Yang S, Ohta A, Naito S, Chiga M, Nomura N, Lin S, Vandewalle A, Ohta E, Sasaki S, Uchida S and Dryer S (2011) Acute Insulin Stimulation Induces Phosphorylation of the Na-Cl Cotransporter in Cultured Distal mpkDCT Cells and Mouse Kidney, PLoS ONE, 10.1371/journal.pone.0024277, 6:8, (e24277) Ohno M, Uchida K, Ohashi T, Nitta K, Ohta A, Chiga M, Sasaki S and Uchida S (2011) Immunolocalization of WNK4 in mouse kidney, Histochemistry and Cell Biology, 10.1007/s00418-011-0827-x, 136:1, (25-35), Online publication date: 1-Jul-2011. Stowasser M, Pimenta E and Gordon R (2011) Familial or Genetic Primary Aldosteronism and Gordon Syndrome, Endocrinology and Metabolism Clinics of North America, 10.1016/j.ecl.2011.01.007, 40:2, (343-368), Online publication date: 1-Jun-2011. Chiga M, Rafiqi F, Alessi D, Sohara E, Ohta A, Rai T, Sasaki S and Uchida S (2011) Phenotypes of pseudohypoaldosteronism type II caused by the WNK4 D561A missense mutation are dependent on the WNK-OSR1/SPAK kinase cascade, Journal of Cell Science, 10.1242/jcs.084111, 124:9, (1391-1395), Online publication date: 1-May-2011. Hedayati S, Elsayed E and Reilly R (2011) Non-pharmacological aspects of blood pressure management: what are the data?, Kidney International, 10.1038/ki.2011.46, 79:10, (1061-1070), Online publication date: 1-May-2011. Biro P, Vagts D, Emmig U and Pasch T (2011) G Anästhesie bei seltenen Erkrankungen, 10.1007/978-3-642-01047-7_7, (85-94), . Uchida S (2010) Pathophysiological roles of WNK kinases in the kidney, Pflügers Archiv - European Journal of Physiology, 10.1007/s00424-010-0848-7, 460:4, (695-702), Online publication date: 1-Sep-2010. Yang S, Hsu Y, Chiga M, Rai T, Sasaki S, Uchida S and Lin S (2010) Mechanisms for Hypercalciuria in Pseudohypoaldosteronism Type II-Causing WNK4 Knock-In Mice, Endocrinology, 10.1210/en.2009-0951, 151:4, (1829-1836), Online publication date: 1-Apr-2010. Weiner I, Linas S and Wingo C (2010) Disorders of Potassium Metabolism Comprehensive Clinical Nephrology, 10.1016/B978-0-323-05876-6.00009-5, (118-129), . Ohta A, Rai T, Yui N, Chiga M, Yang S, Lin S, Sohara E, Sasaki S and Uchida S (2009) Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion and lowers blood pressure, Human Molecular Genetics, 10.1093/hmg/ddp344, 18:20, (3978-3986), Online publication date: 15-Oct-2009., Online publication date: 15-Oct-2009. Gamba G (2009) The thiazide-sensitive Na + -Cl − cotransporter: molecular biology, functional properties, and regulation by WNKs , American Journal of Physiology-Renal Physiology, 10.1152/ajprenal.00159.2009, 297:4, (F838-F848), Online publication date: 1-Oct-2009. Vehaskari V (2009) Heritable forms of hypertension, Pediatric Nephrology, 10.1007/s00467-007-0537-8, 24:10, (1929-1937), Online publication date: 1-Oct-2009. Rodan A and Huang C (2009) Distal potassium handling based on flow modulation of maxi-K channel activity, Current Opinion in Nephrology and Hypertension, 10.1097/MNH.0b013e32832c75d8, 18:4, (350-355), Online publication date: 1-Jul-2009. (2009) Adrenal Gland Endocrine and Metabolic Disorders, 10.1201/9781420079364.ch7, (277-316), Online publication date: 17-Jun-2009. Newhouse S, Farrall M, Wallace C, Hoti M, Burke B, Howard P, Onipinla A, Lee K, Shaw-Hawkins S, Dobson R, Brown M, Samani N, Dominiczak A, Connell J, Lathrop G, Kooner J, Chambers J, Elliott P, Clarke R, Collins R, Laan M, Org E, Juhanson P, Veldre G, Viigimaa M, Eyheramendy S, Cappuccio F, Ji C, Iacone R, Strazzullo P, Kumari M, Marmot M, Brunner E, Caulfield M, Munroe P and Kronenberg F (2009) Polymorphisms in the WNK1 Gene Are Associated with Blood Pressure Variation and Urinary Potassium Excretion, PLoS ONE, 10.1371/journal.pone.0005003, 4:4, (e5003) Uchida S (2009) Molecular Pathogenesis of Congenital Hypertensive Disease - Pseudohypoaldosteronism Type II and WNK4遺伝性高血圧疾患の分子病態―偽性低アルドステロン症II型とWNK4―, Nihon Naika Gakkai Zasshi, 10.2169/naika.98.1720, 98:7, (1720-1725), . Moser D, Ekawardhani S, Kumsta R, Palmason H, Bock C, Athanassiadou Z, Lesch K and Meyer J (2008) Functional Analysis of a Potassium-Chloride Co-Transporter 3 (SLC12A6) Promoter Polymorphism Leading to an Additional DNA Methylation Site, Neuropsychopharmacology, 10.1038/npp.2008.77, 34:2, (458-467), Online publication date: 1-Jan-2009. Quigley R (2009) Renal Tubular Acidosis Pediatric Nephrology, 10.1007/978-3-540-76341-3_39, (979-1003), . Chiga M, Rai T, Yang S, Ohta A, Takizawa T, Sasaki S and Uchida S (2008) Dietary salt regulates the phosphorylation of OSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone, Kidney International, 10.1038/ki.2008.451, 74:11, (1403-1409), Online publication date: 1-Dec-2008. Wang H, Liu Z and Huang C (2008) Domains of WNK1 kinase in the regulation of ROMK1, American Journal of Physiology-Renal Physiology, 10.1152/ajprenal.90287.2008, 295:2, (F438-F445), Online publication date: 1-Aug-2008. Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B and Ning G (2008) A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene, Endocrine, 10.1007/s12020-008-9084-8, 33:3, (230-234), Online publication date: 1-Jun-2008. Krapf R, Seldin D and Alpern R (2008) Clinical Syndromes of Metabolic Acidosis Seldin and Giebisch's The Kidney, 10.1016/B978-012088488-9.50062-0, (1667-1720), . Gowrishankar M and Pinsk M (2008) Renal Tubular Acidosis Comprehensive Pediatric Nephrology, 10.1016/B978-0-323-04883-5.50037-4, (477-488), . Huang C and Kuo E (2007) Mechanisms of Disease: WNK-ing at the mechanism of salt-sensitive hypertension, Nature Clinical Practice Nephrology, 10.1038/ncpneph0638, 3:11, (623-630), Online publication date: 1-Nov-2007. Riepe F (2014) Molecular pathogenesis of renal pseudohypoaldosteronism type 1, Expert Review of Endocrinology & Metabolism, 10.1586/17446651.2.3.407, 2:3, (407-419), Online publication date: 1-May-2007. Yang S, Morimoto T, Rai T, Chiga M, Sohara E, Ohno M, Uchida K, Lin S, Moriguchi T, Shibuya H, Kondo Y, Sasaki S and Uchida S (2007) Molecular Pathogenesis of Pseudohypoaldosteronism Type II: Generation an
Referência(s)